匯豐唱淡CoreWeave(CRWV.US)客源太集中 料股價或瀉逾70%
匯豐銀行首次就美國雲端計算公司CoreWeave(CRWV.US)發表報告,予其「減持」評級,目標價32美元,即較周三收市價潛在跌幅超過77%。
匯豐分析員Abhishek Shukla指出,CoreWeave主要收入來自少數大客戶,當中包括微軟、OpenAI及英偉達,惟客戶並未採用CoreWeave的軟件服務,削弱公司產品的競爭力與客戶黏性。今年首季,CoreWeave有72%收入來自微軟,微軟與OpenAI更佔據CoreWeave大部分積壓訂單。
報告亦指出,CoreWeave股價自3月底上市以來已飆升逾240%,認為其估值過高。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.